.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Boehringer Ingelheim
Express Scripts
Moodys
Daiichi Sankyo
Cipla
Baxter
Mallinckrodt
Argus Health
Accenture

Generated: September 25, 2017

DrugPatentWatch Database Preview

Mechanism of Action: Dopamine D2 Antagonists

« Back to Dashboard
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
DROPERIDOL
droperidol
INJECTABLE;INJECTION071981-001Feb 29, 1988APRXNoNo► Subscribe► Subscribe► Subscribe
Luitpold
DROPERIDOL
droperidol
INJECTABLE;INJECTION072123-001Oct 24, 1988APRXNoNo► Subscribe► Subscribe► Subscribe
Emcure Pharms Ltd
METOCLOPRAMIDE
metoclopramide hydrochloride
INJECTABLE;INJECTION204756-001Dec 20, 2013APRXNoNo► Subscribe► Subscribe► Subscribe
Par Pharm Inc
METOCLOPRAMIDE HYDROCHLORIDE
metoclopramide hydrochloride
TABLET;ORAL070581-001Oct 17, 1985ABRXNoNo► Subscribe► Subscribe► Subscribe
Ani Pharms
METOCLOPRAMIDE HYDROCHLORIDE
metoclopramide hydrochloride
SOLUTION;ORAL071402-001Jun 25, 1993AARXNoNo► Subscribe► Subscribe► Subscribe
Teva
METOCLOPRAMIDE HYDROCHLORIDE
metoclopramide hydrochloride
TABLET;ORAL070184-001Jul 29, 1985ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
METOCLOPRAMIDE HYDROCHLORIDE
metoclopramide hydrochloride
INJECTABLE;INJECTION073135-001Nov 27, 1991APRXNoNo► Subscribe► Subscribe► Subscribe
Vistapharm
METOCLOPRAMIDE HYDROCHLORIDE
metoclopramide hydrochloride
SOLUTION;ORAL075051-001Jan 26, 2001AARXNoNo► Subscribe► Subscribe► Subscribe
Teva
METOCLOPRAMIDE HYDROCHLORIDE
metoclopramide hydrochloride
TABLET;ORAL072801-001Jun 15, 1993ABRXNoNo► Subscribe► Subscribe► Subscribe
Novel Labs Inc
METOCLOPRAMIDE HYDROCHLORIDE
metoclopramide hydrochloride
TABLET, ORALLY DISINTEGRATING;ORAL202191-001Aug 15, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
US Department of Justice
Citi
Boehringer Ingelheim
Farmers Insurance
Fish and Richardson
AstraZeneca
Novartis
UBS
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot